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Abstract
Background: Molecular diagnosis using urine is established for many sexually transmitted diseases and is increasingly used
to diagnose tumours and other infectious diseases. Storage of urine prior to analysis, whether due to home collection or
bio-banking, is increasingly advocated yet no best practice has emerged. Here, we examined the stability of DNA in stored
urine in two populations over 28 days.
Methodology: Urine from 40 (20 male) healthy volunteers from two populations, Italy and Zambia, was stored at four
different temperatures (RT, 4uC, 220uC & 280uC) with and without EDTA preservative solution. Urines were extracted at
days 0, 1, 3, 7 and 28 after storage. Human DNA content was measured using multi-copy (ALU J) and single copy (TLR2)
targets by quantitative real-time PCR. Zambian and Italian samples contained comparable DNA quantity at time zero.
Generally, two trends were observed during storage; no degradation, or rapid degradation from days 0 to 7 followed by
little further degradation to 28 days. The biphasic degradation was always observed in Zambia regardless of storage
conditions, but only twice in Italy.
Conclusion: Site-specific differences in urine composition significantly affect the stability of DNA during storage. Assessing
the quality of stored urine for molecular analysis, by using the type of strategy described here, is paramount before these
samples are used for molecular prognostic monitoring, genetic analyses and disease diagnosis.
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Introduction
Molecular diagnosis, where nucleic acids are measured in the
context of a disease, is a multistep process requiring collection,
storage, and extraction of a sample prior to analysis. Diagnostic
samples come in many guises ranging from solid biopsies to liquid
material and their sampling can require highly invasive procedures.
Urine represents the ideal clinical sample, being easy to collect and
homogenous, so less likely to suffer from sample bias that may affect
other material, such as a biopsy. The existence of DNA in excreted
urine is well established and this represents a potentially useful
source of genetic material. DNA arising from cells shed into the
lumen of genitourinary tract can be used for the detection of genetic
anomalies and neoplasia associated with the bladder, prostate or
kidney [1,2]. In addition, some infections are accompanied by the
appearance in the urine of the causative virus or bacterium where
the kidney or bladder are involved in the pathogenesis, or as a
consequence of loss of the renal barrier integrity [3].
The molecular detection from urine of pathogens that infect the
genitourinary system is frequently performed [4]. The use of urine
as a sample for non-genitourinary infections has also been
successfully reported in tuberculosis [5], leishmaniasis [6] and
malaria [7], although in this context it is not widespread. One of
the reasons for this may be due to the high variability in the
reported efficacy of detection. Tuberculosis (TB) is a case in point;
of seven studies reporting amplification of Mycobacterium tuberculosis
DNA using urine as a diagnostic sample [5,8,9,10,11,12,13],
detection sensitivities range from ,30% [9,10] to .70% [5,8]
(reviewed in [14]). Certainly, one of the variables potentially
contributing to this variation was urine storage.
Reports on how best to store urine for molecular detection are
sparse. Studies whose primary outcome was the measurement of
bacterial DNA have concluded that storage at 4uC for up to 30
days with EDTA [15], or for 1 week without EDTA [16] did not
affect molecular detection. Studies whose primary outcome was
the recovery and analysis of human DNA have concluded that
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storing urine at room temperature with sodium azide over 30 days
[17] or at 220uC with EDTA over 72 days [18], provides the best
storage method. Furthermore, in other studies, useful human
molecular analyses have been obtained from urine stored without
preservative at 220uC for up to 25 years [19] and up to 7 years
[20]. Whilst recorded differences in optimal storage conditions are
also a function of the extraction method, outcome measure and
the nature of the nucleic acid measured (for example, cell-free or
cellular, single or double stranded, RNA or DNA), the
recommendations produced by these studies vary, suggesting
differences in the stability of their respective urine samples.
To investigate this in detail, we measured the stability of urinary
DNA over 28 days, at four commonly examined storage
temperatures, with and without the urine preservative EDTA at
two geographically distinct sites. Our findings reflect the
contradictions in the existing literature, as we observed significant
variability in urinary DNA stability irrespective of storage
conditions when sampled from different sources. We would
recommend that researchers undertaking molecular analysis of
urine use this type of approach to either conduct their own stability
study or assess the status of their banked samples. These findings
apply to all cases (for example, molecular diagnosis, prognostic
monitoring, genetic/epidemiological screening and forensic test-
ing) where molecular analysis of stored urine provides the outcome
measure.
Materials and Methods
Ethics Statement
All study participants gave written informed consent in
accordance with local guidelines and the study was approved by
The University of Zambia Research Ethics Committee in Zambia
and the Ethics Board of the National Institute for Infectious
Diseases Lazzaro Spallanzani in Italy.
Study participants
20 (10 male) healthy volunteers were enrolled at the National
Institute for Infectious Diseases L. Spallanzani (INMI), Rome,
Italy and an additional 20 (10 male) healthy volunteers were
enrolled at University Teaching Hospital (UTH), Lusaka, Zambia.
A second group of 20 (10 male) healthy volunteers were enrolled at
a later date at INMI to further investigate the findings when urine
is stored at 220uC. Participants were confirmed to be free from
urinary tract infection using a commercial dipstick (Multistix,
Bayer, Newbury, UK: UTH), or automated (Aution Max,
Menarini, Italy & Sysmex UF100, Dasit, Italy: INMI).
Urine specimen collection and storage
Urine specimens were collected between 0700 and 1000 hours
and stored as per storage schedule (described below). Urine
processing and sampling was performed within 20 minutes of
collection. 50 ml of mid-stream urine was collected from each
volunteer, and immediately separated into two 25 ml storage
fractions. One fraction was stored as undiluted urine and the other
with ethylenediaminetetracetic-Tris-HCl, pH 8.5 (EDTA solu-
tion). In a small pilot investigation in Italy, we determined that the
recovery of human DNA from samples stored with 40 mM or
10 mM final concentration of EDTA at 220uC for 7 days showed
the same considerable degradation (data not shown). This was
contrary to the data produced from a previous study by Milde et al.
which investigated 40 mM EDTA for storage of urine over three
months [18]. In order to examine the effect of EDTA on urinary
DNA stability over time under a number of conditions, and to
replicate the Milde study, EDTA was added to a final
concentration of 40 mM in the Italian arm of the study. In the
Zambian arm of the study EDTA at 10 mM was used as this
corresponds to the concentration of EDTA commonly present in
commercially available urine preservative kits [21,22,23]. These
are used for sample transport and are potentially good candidates
for the increasingly popular biobanking of samples. To avoid the
potential of experimentally induced trends, and for logistical
reasons, sampling was staggered so that the full time course for 20
volunteers took approximately three months; consequently
extractions of different volunteer urine samples from different
storage times were frequently performed simultaneously. Further-
more all the same time points under different storage conditions
for the same individual’s urine sample were extracted together.
The complexities of the study and logistical reasons prevented us
from examining both preservative concentrations at both sites
during the allotted timeframe. One ml aliquots of both storage
fractions were stored at room temperature (,18–22uC in Italy,
,19–25uC in Zambia), +4uC, 220uC, and 280uC. The stored
urine aliquots were thawed and processed on days 1, 3, 7 and 28
following collection. An additional aliquot of urine was immedi-
ately processed for DNA extraction (day 0). To further investigate
the specific findings in the Italian samples at 220uC, we repeated
the experiment using a further 20 volunteers and investigated
storage without additive and with 40 mM EDTA over seven days.
DNA isolation
DNA was isolated from urine following a protocol to specifically
purify small nucleic acids previously developed at University
College London in collaboration with Xenomics Inc. (New York,
USA). DNA was captured from 1 ml of urine by adding 30 ml of
Q-sepharose (GE-Healthcare
TM
, Little Chalfont, UK) and incu-
bated at room temperature for 30 minutes with constant mixing.
The Q-sepharose was pelleted and washed with 261 ml 400 mM
NaCl (Sigma, Dorset, UK) followed by 161 ml 550 mM NaCl.
Captured DNA was eluted from the sepharose using 560 ml of lysis
buffer (AVL) and further purified using the QiAmp Viral Mini kit
following manufacturer’s instructions (Qiagen, Valencia, USA).
DNA was eluted into 100 ml of PCR grade water and stored in
25 ml aliquots at 280uC before PCR analysis.
Real time PCR
Three quantitative real-time PCR reactions were performed during
this study following the Minimum Information for publication of
Quantitative real-time PCR Experiments (MIQE) guidelines [24], and
further information on data analysis and methodology is summarized
in the supplementary tables S1 to S4. To ensure that different sites
conducted comparable analysis, all reactions and plasmid standards
were developed at University College London and quality assessed
before shipping to the respective experimental sites. Repeat quality
assessment was then performed at each experimental site to ensure
stable transport prior to qPCR analysis. Consequently all experimen-
tation used exactly the same standards, primer and probe batches.
Amplification of the single copy gene for human toll-like receptor 2
(TLR2) (750 nM forward primer TTGCTGGACTTACCTTCC-
TTG, 750 nM reverse primer TGACTTCAAACTTTTTG-
GCTCA) and the multi copy human target ALU J (600 nM forward
CAACATAGTGAAACCCCGTCTCT & 600 nM reverse primer
GCCTCAGCCTCCCGAGTAG) were targeted to measure human
DNA content, and the SPUD inhibition assay to assess inhibition. The
SPUD reaction, which has been previously described [25], was
performed on all extracts prior to other qPCR analyses. All real-time
qPCR reactions were conducted in 12.5 ml volumes in a Rotorgene
6000 thermocycler with amplification measured by excitation at
470 nm and acquisition of fluorescence at 510 nm following each
DNA Analysis of Stored Urine
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extension. PCR efficiencies were estimated using 10 fold dilution series
(comprising linearised plasmid containing amplicon) according to the
formula E=10(21/slope)21. Evaluation of the presence of inhibitors in
the DNA extracts was performed using the SPUD protocol as
previously described [26]. Inhibition assessment was performed on
5 ml isolated DNA and 0.5 ml of isolated DNA (equivalent 50 ml and
5 ml volumes of urine respectively). Inhibition reactions were assessed
using 1,000 copies of the SPUD amplicon. Following inhibition
assessment ALU J and TLR2 reactions were performed using 0.5 ml
of DNA extract (equivalent to 5 ml of urine).
Pico green measurement of DNA extracts
PicoGreen assessments were performed following manufactur-
ers’ instructions (Invitrogen, Carlsbad, CA, USA). A standard
curve (150, 100, 75, 50, 25, 10 & 5 pg/ml) was generated using
lambda DNA included by the manufacturer. 20 ml analysis
volumes comprising 10 ul of lambda standard or undiluted
samples, and 10 ml Quant-iT PicoGreen reagent (diluted 200 fold
using 1X TE) were analysed. Fluorometric analysis using the
rotorgene 6000 was performed using the following parameters: a 2
minute incubation at 50uC followed by ten ten second incubations
at 60uC and fluorescence measured by excitation at 470 nm and
acquisition at 510 nm following each 60uC incubation.
Data presentation and statistical analysis
All data was assessed for normality using the D’Agostino &
Pearson omnibus normality test. Day 0 data was compared using
MannWhitney U test. To assess the effect of storage on DNA
stability, qPCR and pico green data was log transformed and 95%
confidence intervals (CI) calculated. Exponentiated data was plotted
as geometric mean +/295% CI. ALU J and TLR2 data was
compared with pico green analysis using the Spearman rank test.
Results
Participant’s age and urine analysis
At INMI the mean age of participants was 37.3 years (range
26–60 years) for the first group and 38.1 (range 28–55 years) for
the second group. At UTH the mean age was 24.8 years (range 7–
45 years). All volunteers had urinary protein, nitrite, glucose,
ketone, pH, specific gravity, urobilirubin, and haemoglobin within
normal reference ranges. Bacteria, blood cells (erythrocytes,
leucocytes) and epithelial cells were also within the normal
reference ranges for all donors, except three menstruating females
whose urine contained traces of blood.
PCR inhibition
PCR inhibition was detected in all samples when 50 ml effective
volume of urine (5 ml of extract) was used. A ten-fold dilution of
the extracted DNA samples removed this inhibition from all
extracts and the remainder of the analysis was performed using the
effective urine volume of 5 ml per reaction.
DNA measurements from fresh human urine
The base line DNA measurement using the ALU J assays
ranged from 30,000 to 10,450,000 copies/ 5 ml of urine. All data
gave a log normal distribution. Furthermore the geometric mean
was 430,000 copies less (p = 0.009) in males from Italy (mean 34.5
years) than in Italian females (mean 40.1 years) (figure 1A). The
TLR2 data measurement demonstrated a similar result to that of
ALU J (figure 1B), but with considerably lower copies as expected
for a single copy target. There was no difference between male
(mean 26.5 years) and female (mean 23 years) DNA quantity from
Zambian participants or between Italian females and the all
Zambian data (figure 1A and 1B). Although the Italian male data
was different it fell within the range of the other baseline data
(figure 2). Furthermore the data remained log normally distributed
when both sites and sexes were combined.
Effects of storage temperature on stability of DNA in
urine
When the untreated urine from Italian samples was stored at
room temperature on average ,96.9% of the original ALU J
signal was lost by day 28 (figure 3A). On average,,74.6% was lost
after 28 days when stored at 220uC, ,45.3% at 4uC and the
Figure 1. Baseline (day 0) assessment of human DNA. The amplification of multicopy ALU J sequence (A) and single copy TLR2 (B) sequences
were comparable across the populations. Italian males had significantly less human DNA at baseline than females. No such sex difference was
observed for the Zambian urines. Scatter plot of baseline data showing geometric mean.
doi:10.1371/journal.pone.0006985.g001
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degradation was completely halted when stored at 280uC. In
contrast, the loss of ALU J signal in the Zambian urines without
preservative was on average .99% after 28 days with all storage
temperatures (figure 3B). Even after only 7 days in storage the loss
was on average ,98.8%. The TLR2 data was comparable to the
ALU J data, although because the starting copy was much lower,
any decrease in stability generally led to complete loss of signal
(data not shown). There was no difference in the degradation
trends between samples from the male and female volunteers at
either site.
Effects of EDTA and storage temperature on stability of
DNA in urine
The addition of 40 mM EDTA to the Italian samples prevented
degradation for 28 days when the samples were stored at room
temperature, 4uC and 280uC; with an average loss of only 1.6%
compared to baseline (data not shown). However, for urines stored
at 220uC the addition of 40 mM EDTA did not prevent a
,94.7% loss of DNA by day 28 (figure 4). With the Zambian
samples, the addition of 10 mM EDTA solution, reflecting many
commercially available urine preservation kits [21,22,23], had no
stabilising effect regardless of storage temperature (data not
shown). At this site, an average of ,98.9% of the baseline DNA
quantity was lost by day 7, increasing to ,99.3% by day 28.
Detailed assessment of storage at 220uC
When the samples were stored at 220uC the untreated Italian
sample showed a linear degradation of ,74.6% of the original
amount over 28 days (figure 4). This was different from the biphasic
degradation observed when the Italian samples were stored with
40 mM EDTA solution or in all storage conditions with the
Zambian samples. The degradation seen in the Italian samples with
EDTA resembled data from a preliminary study we performed at
the same site comparing the effect of 10 mM and 40 mMEDTA on
urine samples stored at220uC for 7 days (data not shown). Neither
10 mM or 40 mMEDTA concentration stabilised urinary DNA. In
our current study, the biphasic degradation observed was
characterised by a more rapid loss of the ALU J signal to day
seven, followed by a cessation or much reduced degradation to 28
days (figure 4). The Zambian urines showed the same trend in
degradation at220uC regardless of the presence of EDTA (figure 4).
To confirm this finding the Italian analysis was repeated on a
second group of volunteers by storing 20 healthy urine samples for
seven days and assessed using the ALU J and TLR2 qPCR assays as
well as by measuring total DNA using pico green. When urine was
stored at 220 with 40 mM EDTA the degradation in the second
group was identical to the first group (figure 5). Furthermore
assessment of these samples using the Pico Green DNA measure-
ment method confirmed the qPCR findings at220uC with 40 mM
EDTA (figure 6A) and supported the use of qPCR human targets as
a surrogate measurement of total urinary DNA (figure 6B). We
found that ,100,000 copies of ALU J and ,100 copies of TLR2
are equivalent to ,47 pg and ,65 pg of total DNA respectively.
Discussion
Our data show that the stability of human DNA in urine is
dependent on geographic origin. The variation in stability of
human DNA is presumably due to differences in the urinary
matrix between locations. Of the several factors we examined (and
potentially important in determining the stability of human DNA
in urine): sex, two geographically distinct sites, addition of EDTA
as a preserving solution, storage temperature and duration; only
study location and the addition of EDTA correlated with stability.
Baseline DNA measurements showed that Italian, but not
Zambian, males had decreased urinary DNA compared with
females, although this remained within the log normal distribution.
A similar reduction in the amount of human urinary DNA at
baseline in males has been recorded for studies in USA [17,27],
Germany [18,20], but was not observed in healthy individuals
from Russia [28] or the Zambian individuals in this study.
Irrespective of sex, the Italian and Zambian samples had
comparable distribution at baseline, which ranges over two orders
of magnitude. A considerable variation in total nucleic acid content of
urine has been previously documented, for example, 27–189 ng/ml
[28], 50–200 ng/ml [18]. By using qPCR for multi- and single target
human genes as a surrogate measure for urinary DNA content we
have accurately quantified this range in a number of healthy
individuals. The ALU J assay amplifies a family of short interspersed
nuclear elements from the ALU group which comprise over 10% of
the human genome [29]. Therefore, ALU J provides a useful
approximate measure of genomic DNA which is able to record
differences in quantity of two orders of magnitude, and due to the
high initial copy number, has the capacity to record considerable
degradation of human DNA over time. Furthermore, the similarities
between the distribution of our two sites suggests this approach
provides a facile tool to measure urinary DNA content applicable to
ongoing studies and bio-banks from different populations.
The addition of EDTA to a final concentration of 10 mM did not
stabilise urinary DNA in Zambia. Zambian urines essentially
demonstrated a biphasic.2 log degradation over time, irrelevant of
storage temperature or addition of EDTA. The urine preservative
EDTA is commonly employed at a final concentration of 10 mM by
commercially available urine transport tubes sold specifically for
down-streammolecular analysis [15,21,23]. Although this approach
is highly suitable to large scale studies in less developed countries, we
would not recommend this concentration of EDTA to be used in
further studies at our Zambian site. At our Italian site, the addition
of EDTA did improve urinary DNA stability under most, but not
Figure 2. Baseline (day 0) ALU J DNA sequences are log
normally distributed. Italian male data contains less human DNA
compared to females but still falls within the range of the all other
baseline data. The data remain log normally distributed when both sites
and sexes are combined. Box and whisker plots showing median, 25th
and 75th percentiles and range.
doi:10.1371/journal.pone.0006985.g002
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all, conditions examined. EDTA added to a final concentration of
40 mM did not stabilise the Italian urines stored at 220uC for
28 days, and actually decreased stability compared to samples
containing no preservative. These findings were contrary to the
previous report [18] on which this aspect of the study was modelled.
In this study, we have not investigated whether 40 mM EDTA
would have stabilised Zambian urinary DNA, however, we do
clearly demonstrate that Zambian urinary DNA is far less stable
under storage than Italian urinary DNA. Furthermore, it is clear
that urine DNA stability observed in one population cannot be
assumed to be representative of another.
An additional question posed by this study is what is the source
of this degradation? At this stage it is unclear, whether the reason
for this is due to genetic, dietary, climatic or other differences,
observed in the Zambian samples. Our most informative result
may be that the Italian urines are stored at 220uC degrade in the
presence of EDTA. This degradation is comparable to that
observed in all the Zambian samples (figure 4) and is unique to this
temperature under these conditions: addition of EDTA completely
stabilises Italian urinary DNA both at temperatures above and
below 220uC. The storage temperature, addition of EDTA and
raised pH suggests that the observed degradation is not due to
nuclease digestion, but rather an alternative mechanism like the
eutectic phenomenon. This is certainly able to synthesis nucleic
acids, and increasing solute concentration has also been reported
to degrade them [30] and may explain this unexpected
observation. Further work is required to test this theory and
establish if this or other mechanisms are responsible for the other
nucleic acid degradation observed in this study.
Whatever the cause of the observed differences in degradation it
is clear that the storage methods investigated, and previously used
[16,17,18], are not universally suitable. This is likely to explain the
contradictory conclusions of previous stability studies and may, in
part, contribute to differences observed in the TB diagnostic studies
using urine as a clinical sample, described above. A method for
universal storage of urine optimised for subsequent nucleic acid
analysis remains to be described and our findings have implications
for bio-bank setup and storage, which are currently gaining
prominence. For example the UK bio-bank stores urine for a wide
range of measurements including DNA analysis; urine is stored at
280uC and in liquid N2 [31,32]. If the UK sample stability reflects
our Italian volunteers, or the Dutch female urines stored for 15–25
Figure 3. The effect of storage temperature on untreated urine from two populations over 28 days. Human DNA, as measured by the
ALU J assay, is quite stable in all temperatures in Italy (A) except room temperature where considerable degradation is observed. In Zambia (B)
human DNA is rapidly lost at all of the temperatures examined. Geometric means +/295% confidence intervals are plotted for each treatment.
doi:10.1371/journal.pone.0006985.g003
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Figure 4. Direct comparison of human DNA stability in samples stored at220uC over 28 days. The Italian urines stored with 40 mM EDTA
at220 C show the same biphasic degradation of human DNA observed in all Zambian urines. This biphasic degradation of the Zambian urines occurs
in both the presence and absence of EDTA. Geometric means +/295% confidence intervals are plotted for each treatment.
doi:10.1371/journal.pone.0006985.g004
Figure 5. Comparison of DNA stability between Italian groups 1 and 2. Stability of human DNA in urine over 7 days compared between
groups 1 and 2 demonstrate that the stability trend observed for the second analyses is highly consistent with the first. Specifically the degradation
when urine is stored with EDTA is almost identical between the two groups. Geometric means +/295% confidence intervals are plotted for each
treatment.
doi:10.1371/journal.pone.0006985.g005
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years before molecular analysis [19], then the280uC storage will be
suitable for subsequent DNA analysis. If they resemble the Zambian
samples, then it is likely that the DNA suitability for molecular
analyses will be greatly reduced even after one week in storage.
In summary, we have demonstrated that urinary DNA stability
can be highly variable. Further work is required to identify the
source of this variability and the case of the degradation. However
our findings likely explain why there has been considerable
disagreement in the literature as to how best to store urine for
molecular analysis. We also present a novel solution, using the
ALU J assay, to assess the status of existing urine bio-banks for
DNA degradation and the suitability of the chosen method of
storage. These findings and methodologies should be considered
for collection, shipping and storage of urine for subsequent
molecular diagnosis, therapy monitoring and genetic analysis.
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